SRx Health to acquire EMJX in all-stock deal valued at ~$55M; Eric Jackson to become CEO and Chairman

SRx Health Solutions, Inc.

Aggregate purchase price ~$55M payable in stock; transaction unanimously approved by SRx Health Board.
Closing expected Q1 2026; subject to SRx shareholder approval, SEC filings, listing approval, and other conditions.
Upon closing, Eric M. Jackson (EMJX founder/CEO) to serve as CEO and Chairman of combined company; combined entity to operate under EMJX name.
EMJX is a Gen2 digital-asset treasury platform using quantitative models and AI for multi-asset risk management; target is to reduce reliance on equity dilution.
The IP asset includes an AI algorithm designed to outperform Bitcoin and Ethereum based on trading volatility.

item 1.01item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.